BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 30350359)

  • 1. Tetracycline, nicotinamide, and lesionally administered clobetasol as a therapeutic option to prednisone in patients with bullous pemphigoid: a comparative, retrospective analysis of 106 patients with long-term follow-up.
    Kalinska-Bienias A; Kowalczyk E; Jagielski P; Kowalewski C; Wozniak K
    Int J Dermatol; 2019 Feb; 58(2):172-177. PubMed ID: 30350359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interventions for bullous pemphigoid.
    Singh S; Kirtschig G; Anchan VN; Chi CC; Taghipour K; Boyle RJ; Murrell DF
    Cochrane Database Syst Rev; 2023 Aug; 8(8):CD002292. PubMed ID: 37572360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventions for bullous pemphigoid.
    Kirtschig G; Middleton P; Bennett C; Murrell DF; Wojnarowska F; Khumalo NP
    Cochrane Database Syst Rev; 2010 Oct; 2010(10):CD002292. PubMed ID: 20927731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bullous pemphigoid: a review].
    Bernard P; Charneux J
    Ann Dermatol Venereol; 2011 Mar; 138(3):173-81. PubMed ID: 21397147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of 16 patients with bullous pemphigoid with oral tetracycline and niacinamide and topical clobetasol.
    Hornschuh B; Hamm H; Wever S; Hashimoto T; Schröder U; Bröcker EB; Zillikens D
    J Am Acad Dermatol; 1997 Jan; 36(1):101-3. PubMed ID: 8996271
    [No Abstract]   [Full Text] [Related]  

  • 6. Nicotinamide and tetracycline therapy of bullous pemphigoid.
    Fivenson DP; Breneman DL; Rosen GB; Hersh CS; Cardone S; Mutasim D
    Arch Dermatol; 1994 Jun; 130(6):753-8. PubMed ID: 8002646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bullous pemphigoid successfully controlled by tetracycline and nicotinamide.
    Kolbach DN; Remme JJ; Bos WH; Jonkman MF; De Jong MC; Pas HH; van der Meer JB
    Br J Dermatol; 1995 Jul; 133(1):88-90. PubMed ID: 7669647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of oral and topical corticosteroids in patients with bullous pemphigoid.
    Joly P; Roujeau JC; Benichou J; Picard C; Dreno B; Delaporte E; Vaillant L; D'Incan M; Plantin P; Bedane C; Young P; Bernard P;
    N Engl J Med; 2002 Jan; 346(5):321-7. PubMed ID: 11821508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two decades of using the combination of tetracycline derivatives and niacinamide as steroid-sparing agents in the management of pemphigus: defining a niche for these low toxicity agents.
    McCarty M; Fivenson D
    J Am Acad Dermatol; 2014 Sep; 71(3):475-9. PubMed ID: 24906610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tetracycline and nicotinamide for the treatment of bullous pemphigoid: our experience in Singapore.
    Goon AT; Tan SH; Khoo LS; Tan T
    Singapore Med J; 2000 Jul; 41(7):327-30. PubMed ID: 11026799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two Cases of Dermatitis Herpetiformis Successfully Treated with Tetracycline and Niacinamide.
    Wang Y; Yang B; Zhou G; Zhang F
    Acta Dermatovenerol Croat; 2018 Oct; 26(3):273-275. PubMed ID: 30390734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of bullous pemphigoid.
    Fontaine J; Joly P; Roujeau JC
    J Dermatol; 2003 Feb; 30(2):83-90. PubMed ID: 12692373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of initial disease control in bullous pemphigoid: a retrospective study of hospitalized patients in a single tertiary center.
    Kremer N; Zeeli T; Sprecher E; Geller S
    Int J Dermatol; 2017 Oct; 56(10):1010-1016. PubMed ID: 28856675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interventions for bullous pemphigoid.
    Khumalo N; Kirtschig G; Middleton P; Hollis S; Wojnarowska F; Murrell D
    Cochrane Database Syst Rev; 2003; (3):CD002292. PubMed ID: 12917929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of generalized bullous pemphigoid with oral tetracycline.
    Thomas I; Khorenian S; Arbesfeld DM
    J Am Acad Dermatol; 1993 Jan; 28(1):74-7. PubMed ID: 8425974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interventions for bullous pemphigoid.
    Khumalo N; Kirtschig G; Middleton P; Hollis S; Wojnarowska F; Murrell D
    Cochrane Database Syst Rev; 2005 Jul; (3):CD002292. PubMed ID: 16034874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of topical corticosteroids in bullous pemphigoid in the elderly.
    Joly P; Fontaine J; Roujeau JC
    Drugs Aging; 2005; 22(7):571-6. PubMed ID: 16038572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of bullous pemphigoid with dapsone, methylprednisolone, and topical clobetasol propionate: a retrospective study of 62 cases.
    Schmidt E; Kraensel R; Goebeler M; Sinkgraven R; Bröcker EB; Rzany B; Zillikens D
    Cutis; 2005 Sep; 76(3):205-9. PubMed ID: 16268266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole body application of a potent topical corticosteroid for bullous pemphigoid.
    Terra JB; Potze WJ; Jonkman MF
    J Eur Acad Dermatol Venereol; 2014 Jun; 28(6):712-8. PubMed ID: 23551654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin tears?
    Kazandjian DG; Okulicz JF
    Am J Med; 2006 Aug; 119(8):657-9. PubMed ID: 16887409
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.